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Cytochrome bc1 is a major component of biological energy conversion that exploits an energetically favourable redox reaction to generate a
transmembrane proton gradient. Since the mechanistic details of the coupling of redox and protonation reactions in the active sites are largely
unresolved, we have identified residues that undergo redox-linked protonation state changes. Structure-based Poisson–Boltzmann/Monte Carlo
titration calculations have been performed for completely reduced and completely oxidised cytochrome bc1. Different crystallographically observed
conformations of Glu272 and surrounding residues of the cytochrome b subunit in cytochrome bc1 from Saccharomyces cerevisiae have been
considered in the calculations. Coenzyme Q (CoQ) has been modelled into the CoQ oxidation site (Qo-site). Our results indicate that both
conformational and protonation state changes of Glu272 of cytochrome bmay contribute to the postulated gating of CoQ oxidation. The Rieske iron–
sulphur cluster could be shown to undergo redox-linked protonation state changes of its histidine ligands in the structural context of the CoQ-bound
Qo-site. The proton acceptor role of the CoQ ligands in the CoQ reduction site (Qi-site) is supported by our results. A modified path for proton uptake
towards the Qi-site features a cluster of conserved lysine residues in the cytochrome b (Lys228) and cytochrome c1 subunits (Lys288, Lys289,
Lys296). The cardiolipin molecule bound close to the Qi-site stabilises protons in this cluster of lysine residues.
© 2007 Elsevier B.V. All rights reserved.Keywords: Protonation probability; Titration behaviour; Respiratory chain; Membrane protein; Cardiolipin; Rieske iron–sulphur cluster; Poisson–Boltzmann
electrostatics calculation1. Introduction
The cytochrome bc1 complex (cytochrome bc1) is a key
enzyme of biological energy conversion in bacteria and
mitochondria. It is a multi-subunit transmembrane protein
complex that transfers electrons from reduced coenzyme Q
(CoQ) to a mobile redox-active protein and translocates protonsAbbreviations: CoQ, coenzyme Q; ISP, iron–sulphur protein; FTIR, Fourier
transform infrared spectroscopy; PDB, protein data bank (www.rcsb.org/pdb);
HDBT, hydroxydioxobenzothiazole; PB, Poisson Boltzmann; MC, Monte
Carlo; CDL, cardiolipin; Specific residues are denoted by their single letter
amino acid code, their residue number and a subunit identifier; CYB,
cytochrome b subunit; CYC1, cytochrome c1 subunit; ISP, Rieske iron–sulphur
protein subunit; SU9, small subunit 9
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doi:10.1016/j.bbabio.2007.01.016across the membrane. The free energy of the catalysed redox
reaction is converted into the energy of a transmembrane proton
motive force. In mitochondria, cytochrome bc1 spans the inner
mitochondrial membrane and transfers electrons from ubiquinol
to cytochrome c. Mitochondrial cytochrome bc1 represents
complex III of the respiratory chain.
The coupling between electron transfer and proton transloca-
tion in cytochrome bc1 is based on the so-called modified Q-
cycle mechanism (Fig. 1) [1–3]. The mechanism requires two
CoQ-binding sites and a site for cytochrome c reduction,
connected by chains of protein-bound redox cofactors. Three
different subunits of the complex form the catalytic sites and
bind the cofactors: cytochrome b, cytochrome c1, and the Rieske
iron–sulphur protein (ISP). The oxidation of CoQ is catalysed in
the so-called Qo-site of the complex: the reduced and protonated
quinol form of CoQ is converted into the oxidised and
deprotonated quinone form. The two electrons of this reaction
are transferred to two different electron acceptor groups, namely
Fig. 1. The Q-cycle mechanism of cytochrome bc1. Protons from the oxidation
of quinol in the Qo-site are set free to the intermembrane space. One electron
from the oxidation of quinol is transferred via the high-potential chain of redox
cofactors ([Fe2S2] cluster of the Rieske ISP subunit and haem c1 of cytochrome
c1) to cytochrome c. The second electron is recycled back into the CoQ pool: it
is transferred to the Qi-site via the low-potential chain of redox cofactors (haem
bLand bH of cytochrome b). Two molecules of CoQ have to get oxidised in the
Qo-site to provide the two electrons for complete reduction of one CoQmolecule
in the Qi-site. QH2+2 cyt c(ox)+2 Hmatrix
+ →Q+2 cyt c(red)+4 HIMS
+ is the
overall reaction catalysed by cytochrome bc1. Electron transfer is indicated by
dashed arrows, proton translocation by bold arrows. Q—oxidised CoQ,
quinone. QH2—reduced CoQ, quinol. SQ—stable semiquinone intermediate
in the Qi-site. ISP—iron–sulphur protein. IMS—mitochondrial inter-membrane
space, IMM—inner mitochondrial membrane.
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subunit of the complex) and a Rieske [Fe2S2] iron–sulphur
cluster (bound to the ISP subunit). By movement of its mobile
head domain [4], the Rieske ISP then transfers an electron to the
haem c1 group bound to the cytochrome c1 subunit of
cytochrome bc1. Cytochrome c1 finally reduces the c-type
haem group of the substrate cytochrome c. The second electron
of the oxidation of CoQ is transferred via haem bL and haem bH
of cytochrome b to the so-called Qi-site. In the Qi-site, oxidised
CoQ gets reduced to semiquinone and finally to quinol by two
electrons sequentially arriving from the Qo-site. Since CoQ
oxidation and reduction are coupled to proton release and
uptake, respectively, the location of the two CoQ-binding sites
relative to the membrane links electron transfer to the
translocation of protons across the membrane.
Although the overall scheme of the Q-cycle mechanism is
widely accepted, details of the reactions in the catalytic sites
remain largely unresolved [5,6]. Among the most heavily
debated aspects of cytochrome bc1 catalysis are the nature of
proton acceptor and donor groups [7–11], the nature of the rate-
limiting steps [12,13], the sequence of single proton and
electron transfer steps [12,14], the mechanistic basis of the
bifurcation of electron transfer pathways in the Qo-site [13–18],
and the control of harmful bypass reactions [19–21]. Consider-
able effort has been made to clarify these mechanistic details.
However, this effort resulted in the formulation of differentmechanistic models that are based on often conflicting in-
terpretation of the available experimental data.
To evaluate the conflicting models of Qo- and Qi-site
catalysis, it is necessary to identify redox-linked protonation
state changes in cytochrome bc1, because redox-linked protona-
tion state changes are at the very heart of any mechanism
coupling electron and proton transfer reactions. Several recent
Fourier transform infrared (FTIR) spectroscopy studies [22–27]
have successfully embarked on identifying redox-linked proto-
nation state changes in cytochrome bc1. In this work, we report
redox-linked protonation state changes of cytochrome bc1 that
have been identified from Poisson–Boltzmann/Monte Carlo
titration calculations. The calculations are based on the crystal
structures of cytochrome bc1 from the yeast Saccharomyces
cerevisiae [28–30]. The conformational variability of the Qo-site
observed in different crystal structures has been taken into
account. For different redox states of the complex that
correspond to the experimental conditions of the FTIR studies
we obtain protonation probabilities for all titratable groups in the
protein complex.
In the following, we give some basic theoretical background
and describe the setup of our calculations. We then present and
discuss the redox-linked protonation state changes revealed by
our calculations. A small number of titratable residues were
identified that have markedly different protonation probabilities
in the fully oxidised and fully reduced state of the complex. Our
results support the idea that conformational variability of the Qo-
site plays a role during CoQ oxidation. We observe a coupling
between protonation reactions and conformational transitions
that may be the basis of the recently discussed gating of the Qo-
site reaction [6,19,20]. Concerning the Qi-site, our results
propose a modified path for proton uptake to the active site.
2. Material and computational setup
2.1. Preparation of the crystal structures
Our calculations are based on two different crystal structures of cytochrome
bc1 from S. cerevisiae. These structures contain the Qo-site inhibitors stigmatellin
(PDB code 1KB9, 2.3 Å resolution, Ref. [29]) and hydroxydioxobenzothiazole
(HDBT, PDB code 1P84, 2.5 Å resolution, Ref. [30]), respectively. The HDBT-
inhibited structure contains an additionally refined second cardiolipin molecule
[31]. Both crystal structures comprise nine different subunits. Two copies of each
subunit form the dimeric state of the complex, which is considered to be the
catalytically active state of cytochrome bc1 [32].
In both crystal structures, the Rieske head domain is found in its so-called
b-position, forming the Qo-site together with the cytochrome b subunit.
The crystal structures were prepared for the Poisson–Boltzmann (PB)
calculations using the molecular modelling package CHARMM [33]. All lipids,
detergent and water molecules were retained during the structure preparations.
The desired redox states of the complexwere introduced by assigning appropriate
partial charges to the atoms of the redox cofactors. Hydrogen atom positionswere
constructed and subsequently energy-minimised using the steepest decent (SD)
and conjugate gradient (CG) techniques and short molecular dynamics
simulations as implemented in CHARMM. The minimisation consisted of
1000 SD steps, 500MD steps of 0.2 fs at 100 K, 500MD steps of 0.5 fs at 200 K,
500MD steps of 1 fs at 300 K, 500MD steps of 1 fs at 100 K, 1000 SD steps and
2000 CG steps. The procedure was followed for all states of the system that were
treated in separate PB-calculations. The crystal structures contain antibody
fragments, which bind to the Rieske protein head domain and were used for
cocrystallisation. These antibody fragments were not included in our
Fig. 2. (A) Chemical structure of stigmatellin A contained in the crystal structure
of cytochrome bc1 from S. cerevisae. (B) Chemical structure of oxidised
undecylstigmatellin (UST). (C) Chemical structure of reduced UST. The position
of the highlighted oxygen atom (bold font) has been energyminimised during the
structure preparation procedure, in order obtain an appropriate tetrahedral
geometry at the corresponding ring carbon atom.
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negligible effect on the protonation probabilities of cytochrome bc1.
2.2. Modelling of undecylstigmatellin and CoQ into the Qo-site
In order to obtain results that can be compared to the FTIR data published
by Ritter et al. [25], we have performed calculations on cytochrome bc1
inhibited by undecylstigmatellin (UST). For these calculations, we have used
the stigmatellin-inhibited structure of cytochrome bc1 from S. cerevisiae.
Since the crystal structure contains stigmatellin A which has a different
hydrophobic tail than UST (Fig. 2A and B), we have changed the hydrophobic
tail of stigmatellin A into the simple alkyl chain of UST. The hydrophobic tail
of UST in the Qo-site has been energy minimised using CHARMM. The
details of the minimisation procedure are the same as for the minimisation of
the hydrogen atom positions described above. Since Ritter et al. [25] have
reported changes in the redox state of UST in the Qo-site of cytochrome bc1,
we consider two different redox states of UST in our calculations. The
probable chemical structures of oxidised and reduced UST are shown in Fig.
2B and C, respectively. For both redox states, we have calculated partial
charges using a density functional theory (DFT) approach (see Supplementary
Material).
To obtain mechanistically relevant results, we have performed calculations
on cytochrome bc1 with the substrate CoQ modelled into the Qo-site. Since the
available crystal structures of cytochrome bc1 do not contain CoQ in the Qo-
site, we have followed a modelling procedure that uses structural information
available for another CoQ-binding site, namely the QB-site of the photo-
synthetic reaction centre. The reaction centre has been crystallised with
stigmatellin (PDB code 4PRC) and with CoQ (PDB code 2PRC) in the active
site [34]. The binding mode of stigmatellin is very similar in the Qo-site and
the QB-site. In both sites, the carbonyl oxygen atom of the chromone ring
system of oxidised stigmatellin forms a hydrogen bond towards the nitrogen
atom of a histidine sidechain. The same histidine sidechain coordinates an iron
atom with its other nitrogen atom (the mononuclear iron centre in the reaction
centre and the Rieske cluster in cytochrome bc1). The hydroxy group of the
chromone ring system interacts with an oxygen-containing sidechain (serine in
the reaction centre, glutamate in cytochrome bc1. Using the relative orientation
of stigmatellin and CoQ observed in the crystal structures of the reaction
centre, and the position of stigmatellin in the Qo-site of cytochrome bc1, we
derive the position of CoQ in the Qo-site of cytochrome bc1 from yeast.
Starting from this similarity-based initial positioning, we have performed an
energy minimisation of the hydrophobic tail of CoQ using CHARMM, during
which only minor structural changes are observed. The details of the mini-
misation procedure are the same as for the minimisation of hydrogen atom
positions described above. The tail was modelled to contain one isopren unit.
In the framework of the single-occupancy model [35] we have by this pro-
cedure obtained a reasonable working model of CoQ in the Qo-site (Fig. 3). In
all calculations, the Qi-site contains CoQ as observed in both crystal structures
from S. cerevisiae.
2.3. Addition of a model membrane
To account for the effect of the membrane environment on the electrostatics
of cytochrome bc1 we have added a model membrane around the crystal
structures prepared for the PB-calculations. The membrane is modelled by a
torus-shaped belt of uncharged atoms, placed with HLINK from the TRIP
program package [36]. For the PDB deposited coordinates, the membrane model
extends from yinterface matrix=−61 Å to yinterface intermembrane space=−39 Å along
the membrane normal of the complex. In the PB-calculations, a low dielectric
constant is assigned to the volume occupied by the uncharged membrane atoms,
which thus adequately represent the hydrophobic core of the membrane. Explicit
water molecules were removed from the structures for PB-calculation after
addition of the model membrane.
2.4. Treatment of conformational variability in the Qo-site
As obvious from the crystal structures from S. cerevisiae, the Qo-site of
cytochrome bc1 adopts different conformations in presence of the Qo-siteinhibitors stigmatellin and HDBT. In both crystal structures, the Rieske head
domain is found in its so-called b-position forming the Qo-site together with the
cytochrome b subunit [4]. The most obvious difference between the structures is
the orientation of the sidechain of E272CYB (Fig. 3). E272CYB points towards the
Rieske cluster in the stigmatellin-inhibited complex (referred to as conformation
Glu-FeS), and points towards haem bL in the HDBT-inhibited complex (referred
to as conformation Glu-b). Differences between the two conformations are
limited to residues 265 to 273 of cytochrome b and the sidechain of H253CYB.
We assume that the rest of the complex adopts the conformation observed in the
HDBT-inhibited crystal structure and we keep it fixed in this conformation
during the Monte Carlo calculations. The energy difference between the two
conformations (shown in green and purple in Fig. 3) in presence of CoQ in the
active site has been estimated by a combined molecular mechanics/Poisson–
Boltzmann approach that is detailed in the Supplementary Material. The value
for the conformational energy difference enters into the Monte Carlo
calculations that reveal to which extent the two conformations are populated
in the complex with CoQ in the Qo-site (see below).
2.5. Calculation of protonation probabilities
To characterise protonation probabilities as well as the probabilities of the
different Qo-site conformations, we have performed PB electrostatics and
Metropolis Monte Carlo (MC) titration calculations. The underlying theory is
described in detail in Ref. [37] and [38].
The PB-calculations were performed using multiflex from the MEAD
package [39]. The results describe the energetics of all N titratable groups in
cytochrome bc1 in terms of N intrinsic pK-values and a symmetric N×N matrix
of pairwise interaction energies. The intrinsic pK-values are calculated as shifts
relative to experimentally determined pK-values of appropriate model reactions
in aqueous solution (see Supplementary Material). In our calculations, all
aspartate, glutamate, lysine, arginine, histidine, tyrosine and cysteine residues,
the propionate moieties of the haem groups and the lipid head-groups were
considered titratable. Apart from the Rieske ligand histidines, sidechains that are
involved in covalent or coordination bonds are not considered titratable.
Fig. 3. The substrate CoQ modelled into the Qo-site of cytochrome bc1. The Qo-site is formed by two of the three catalytic subunits of the cytochrome bc1 complex,
namely cytochrome b (CYB, coloured in green) and the Rieske iron–sulphur protein (ISP, coloured in ochre). Different conformations of the Qo-site as observed in the
presence of stigmatellin (coloured in purple: conformation Glu-FeS, Ref. [28]) and HDBT (coloured in green: conformation Glu-b, Ref. [31]) have been considered in
the calculation of protonation probabilities in presence of CoQ in the Qo-site. Differences between the two conformations are limited to residues 265 to 273 of
cytochrome b (the positions of the Cα-atoms in this fragment are labelled by their residue numbers), and the sidechain of H253
CYB. Coordinates outside these regions
are virtually identical in the two structures, and coordinates from the HDBT-inhibited structure have been used for the rest of the complex. The two electron acceptors
of the CoQ oxidation reaction (haem bL and the Rieske cluster), the cysteine and histidine ligands of the Rieske cluster, and residues undergoing redox-linked changes
in their titration behaviour are highlighted. Distances between atoms are given to detail the orientation of CoQ modelled into the active site.
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considered titratable as far as they are resolved in the crystal structures.
Unresolved termini are the N-terminus of the small subunits 6, 7, 8 and 9, and the
C-terminus of cytochrome c1 and the small subunit 9. The effect of these
unresolved termini is considered marginal. Because of their structural flexibility
they can be expected to be well solvated. Their charges are consequently well
shielded and have little effect on the titration behaviour in the rest of the complex.
Neutral blocking groups were attached to replace the unresolved termini.
In contrast to all other titratable groups, model pK-values for the ligand
histidines of the Rieske centre were not determined experimentally, but were
calculated by a combined DFT/PB approach (see Supplementary Material). The
underlying DFT calculations have been shown in previous work on Rieske
proteins to correctly reproduce experimental data in combination with PB-
calculations [41,42]. Since in MEAD titratable groups are considered to adopt
exactly two different protonation forms, the different one-proton equilibria of
the Rieske centre were treated in separate MEAD-calculations, and their relative
energies were then sampled by a subsequent MC analysis. Details of the
treatment of the Rieske centre in the PB/MC-calculations are given in the
Supplementary Material.
The following parameters were used in all PB-calculations: dielectric
constants ε=4 for the protein and the membrane and ε=80 for the aqueous
phase, ionic strength I=0.1 M for the aqueous phase and temperature T=300 K.
Standard partial charges from the CHARMM22 parameter set [33] were used for
the protein. Partial charges for other compounds (Rieske cluster, haem groups,stigmatellin, CoQ and lipids) were derived from density functional theory
calculations performed with the ADF programme suite [43]. Details of these
calculations and resulting charges are given as Supplementary Material. The
calculation of partial charges for the Rieske cluster [41,42] and CoQ [44] has
been reported in previous publications from our group. Bondi radii [45] were
used for all atoms except for hydrogen (rH=1.0 Å).
From the results of the PB-calculations, the pH-dependent energy of a certain
protonation and conformation state can be calculated as
Gðn;kÞ ¼
XN
i
RT ln 10d xðnÞi  xð0Þi
 
pH pK intrðkÞi
 
þ 1
2
XN
i
XN
j
xðnÞi  xð0Þi
 
xðnÞj  xð0Þj
 
W ðkÞi;j þ GðkÞconf ð1Þ
with G(n,k) as the energy of conformation k in protonation state n. A certain
protonation state n is characterised by a protonation state vector Yx
ðnÞ
with the
components xi
(n)=0 if group i is deprotonated, and xi
(n)=1 if group i is protonated.
xi
(0) corresponds to the protonation formof group i in the reference protonation state
of the protein, for which the intrinsic pK-values have been calculated. pKi
intr(k) is the
intrinsic pK of group i in conformation k, which corresponds to the pK-value group
i would have if all other groups were in their reference protonation form.Wi,j
(k), is
the interaction energy between groups i and j in conformation k, with Wi,j=0 for
i= j. N is the total number of titratable groups, R the universal gas constant and T
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(k) accounts for the relative energies of the different
conformations k considered (see above). A separate PB-calculation is performed
for every conformation k.
To obtain the protonation probabilities of all groups i and the probabilities of
the different conformations k as a function of pH, the states (n, k) of Eq. (1) are
sampled by a Metropolis MC algorithm implemented in the programme cmct
[46]. An output ensemble of low energy states is calculated for every pH (pH 0 to
14 in steps of 0.1 pH-units). At a given pH, the protonation probability 〈xi〉(pH) of
a certain group i is equivalent to the probability to find the group protonated in the
MC output ensemble. In the same way, the probability of a certain conformation
can be obtained from the composition of the MC output ensemble.
For every pH-step, the MC calculations consist of 500 equilibration scans
and 20,000 production scans at T=300 K. An MC scan consist of N MC steps,
with N as total number of titratable groups. In one MC step, the protonation form
of one group is changed, and the change in energy is evaluated. After every fifth
MC step, the conformation of the system is changed, and the change in energy is
evaluated. If the end state of a single MC step is accepted, this state is used as
starting state for the next MC step. At the end of each MC production scan, the
state of the system is added to the output ensemble. In double (triple) MC steps,
the protonation form of two (three) groups is changed simultaneously. Double
(triple) MC steps are applied to groups with an interaction energyWi,j larger than
2 (3) pK-units.
2.6. Correlation analysis of protonation probabilities
The electrostatic interaction among multiple titratable groups can lead to
highly unusual titration behaviour of the individual groups [47,48]. To
rationalise such unusual titration curves, the pairwise correlation ci,j (pH) of
protonation probabilities is a valuable analysis tool:
ci;jðpHÞ ¼ hxixjiðpHÞ  hxiiðpHÞdhxjiðpHÞ: ð2Þ
〈xi〉(pH) is the probability to find group i to be protonated, irrespective of the
protonation state of group j, and vice versa for 〈xj〉(pH). In contrast, 〈xixj〉(pH) is
the probability to find both groups to be protonated at the same time. ci,j(pH)
takes values between −0.25 and +0.25. If ci,j(pH) is large and negative, the
groups i and j are anticorrelated, meaning that protonation of group i disfavours
protonation of group j, and vice versa.3. Results
3.1. Redox-linked protonation state changes in cytochrome bc1
In order to identify redox-linked protonation state changes in
cytochrome bc1 we have calculated the titration behaviour of all
titratable groups in the complex, once for the completely
oxidised state, and once for the completely reduced state. In the
oxidised state, all redox cofactors are oxidised and the CoQ
molecules in the Qo- and Qi-site are in the oxidised andFig. 4. Population of the different Qo-site conformations Glu-b and Glu-FeS. (A) Com
site. (B) Completely reduced cytochrome bc1 with reduced and protonated CoQ indeprotonated quinone form. In the reduced state, all redox
cofactors are reduced and the CoQ molecules in the Qo- and Qi-
site are in the reduced and protonated quinol form. In both redox
states, the system is allowed to adopt either of the two Qo-site
conformations.
Twelve titratable groups in cytochrome bc1 display notice-
ably different protonation probabilities in the completely
reduced and the completely oxidised state of the system. For
all other groups, the rmsd between their protonation probabil-
ities in the reduced and oxidised state is below 0.2 for the pH-
range from 0 to 14. The behaviour of most titratable groups does
thus not change between the completely reduced and com-
pletely oxidised state of the system. The catalytically active
dimeric cytochrome bc1 complex from S. cerevisiae consists of
two copies each of nine different subunits. Since equivalent
titration behaviour is observed for all pairs of identical subunits
in the dimeric cytochrome bc1 complex, only the results
obtained for one copy of the respective subunits are discussed,
although all titratable residues in all subunits were considered in
the calculations.
3.2. Conformational variability in the Qo-site with bound CoQ
In the oxidised as well as in the reduced state of cytochrome
bc1 with CoQ in the Qo-site, both Qo-site conformations are
populated. There are redox-linked differences in the population
of the two conformations: in the oxidised complex, almost only
the Glu-b conformation is populated in the physiological pH
range (Fig. 4A). In the reduced complex, in contrast, also the
Glu-FeS conformation is populated to a considerable degree,
namely to about 30% (Fig. 4B). These results indicate that the
two Qo-site conformations observed in the crystal structures of
cytochrome bc1 from S. cerevisiae have sufficiently similar
energies to both be populated when CoQ is bound to the Qo-site.
Furthermore, the population of the two conformations depends
on pH as well as on the redox state of the complex.
In order to test our method for calculating the populations of
the two different conformations, we have performed calcula-
tions on the stigmatellin-inhibited and the HDBT-inhibited
complex. In these calculations, the inhibited complexes were
allowed to adopt either of the two Qo-site conformations. In
agreement with the available crystallographic data, we found
that the stigmatellin-inhibited complex populates exclusivelypletely oxidised cytochrome bc1 with oxidised and deprotonated CoQ in the Qo-
the Qo-site.
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populates exclusively the Glu-b conformation.
3.3. Redox-linked protonation state changes in the Qo-site and
cytochrome c1
Of the twelve groups that show noticeably redox-dependent
titration behaviour, five are located in the Qo-site and one in
cytochrome c1. The titration behaviour of these residues in the
completely oxidised and completely reduced complex is shown
in Fig. 5. The unusual shape of the protonation probability 〈xi〉
(pH) of E272CYB in the reduced complex (Fig. 5A, dashed line)
can be rationalised from its negative correlation with the
protonation probability of H253CYB. As outlined in more detail
below, the pH-dependent correlation ci,j(pH) is a useful tool to
identify which electrostatic interactions between individual
titratable residues render their titration profiles non-sigmoidal.
ci,j (pH) takes values between +0.25 and −0.25. If ci,j (pH) is
close to −0.25, the respective groups i and j are anticorrelated,
meaning that protonation of group i disfavours protonation of
group j, and vice versa. Fig. 6A displays the protonation
probabilities of E272CYB (dashed line), H253CYB (dotted line)Fig. 5. Residues in the Qo-site and the cytochrome c1 head domain of cytochrome
completely reduced state. Oxidised and deprotonated or reduced and protonated Co
sulphur cluster, its Nδ atom is involved in the coordination of an iron atom (Fig. 3).
over the whole pH-range in both the oxidised and the reduced system.and their correlation (solid line) in reduced cytochrome bc1. The
relatively large and negative correlation between these two
titration curves demonstrates that deprotonation of H253CYB
favours protonation of E272CYB. Since the protonation prob-
ability of H253CYB decreases between pH 0 and pH 4, the
probability to find a proton on E272CYB increases in the same pH
range, although the availability of protons in the solution
decreases with increasing pH. In the predominant Glu-b
conformation, the carboxy carbon atom of E272CYB is located
at a distance of 5 Å from the Nε atom of H253CYB (Fig. 3). The
effect of the interaction of E272CYB with H253CYB is amplified
by an interaction with the titratable propionate Amoiety of haem
bL. In the Glu-b conformation, the carboxy carbon atoms of
E272CYB and the propionate are separated by 7Å (Fig. 3). Below
pH 8, the protonation probabilities of the two residue show a
negative correlation (Fig. 6B, solid line). Deprotonation of the
propionate between pH 0 and pH 7 thus leads to an increase in the
protonation probability of E272CYB at low pH-values.
H141CYB (Fig. 5B) and H253CYB (Fig. 5C) show a slight
dependence of their protonation probabilities on the redox state
of the complex. The sidechain of H253CYB occupies different
positions in the Glu-b and Glu-FeS conformations of the Qo-sitebc1 that change their titration behaviour between the completely oxidised and
Q is bound in the Qo-site, respectively. H161
ISP is a ligand to the Rieske iron–
The second Rieske histidine ligand (H181ISP) remains protonated at its Nε atom
Fig. 6. Correlation between the protonation probabilities of E272CYB, H253CYB,
and the propionate A moiety of haem bL can rationalise the irregular shape of the
titration curves of E272CYB and H253CYB. The pH-dependent correlation is
defined as ci,j (pH)= 〈xixj〉(pH)−〈xi〉(pH) · 〈xj〉(pH). In the case of e.g. the first
panel, 〈xi〉 is the protonation probability of E272
CYB, 〈xj〉 is the protonation
probability of H253CYB, and 〈xixj〉 is the probability to find both residues
protonated at the same time. Each panel shows the individual protonation
probability of E272CYB 〈xi〉 (dashed lines), the protonation probability of a
second residue 〈xj〉 (dotted lines), and their respective correlation (solid line)
either in the oxidised or in the reduced state of the system.
Fig. 7. Qo-site residues with different protonation probabilities in completely oxidised
Qo-site. H181
ISP is a ligand to the Rieske iron–sulphur cluster, its Nδ atom coordina
remains protonated at its Nε atom over the whole pH-range in both the oxidised an
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the oxidised state can be rationalised from strong negative
correlation with the protonation probability of E272CYB (Fig.
6C, solid line): deprotonation of E272CYB (dashed line) below
pH 5 favours H253CYB to remain protonated in this pH-range
(dotted line). Also in fully reduced cytochrome bc1, strong
negative correlation between the protonation probabilities of
H253CYB and E272CYB between pH 4 and pH 9 (Fig. 6A, solid
line) can rationalise the plateau in the titration curve of
H253CYB. Deprotonation of E272CYB in this pH-range stabilises
the proton on H253CYB and yields a higher protonation
probability than would be expected for a standard sigmoidal
shape.
The propionate Amoiety of haem bL (Fig. 5D) and the Rieske
ligand H161ISP (Fig. 5E) show a pronounced redox-dependence
of their protonation probabilities. H161ISP coordinates one of the
Rieske iron atoms via its Nδ atom. The second Rieske histidine
ligand, H181ISP, remains protonated over the whole pH-range
studied in both completely reduced and completely oxidised
cytochrome bc1. The titration behaviour of propionate A of
haem bL and H161
ISP points to a coupling between protonation
of these groups and the reduction of haem bL and the Rieske
cluster, respectively.
Outside the Qo- and Qi-sites, the propionate D moiety of
haem c1 is the only titratable group showing a noticeable redox-
linked change in titration behaviour. The weak increase in
protonation probability upon conversion of the completely
oxidised to the completely reduced state of the system (Fig. 5F)
most likely points to a weak coupling between reduction and
protonation of haem c1.
3.4. Redox-linked protonation state changes in the
UST-inhibited Qo-site
In the UST-inhibited complex, E272CYB (Fig. 7A) and
H181ISP (Fig. 7B) display strong redox-linked changes in their
titration behaviour. Both residues have markedly higher
protonation probabilities in the reduced than in the oxidised
state, with reduced and oxidised UST in the active site,
respectively. The second Rieske histidine ligand, H161ISP, is
protonated over the whole pH-range (pH 0 to 14) in both the
oxidised and the reduced complex. The redox-linked change ofand completely reduced cytochrome bc1 with undecylstigmatellin (UST) in the
tes one of the iron atoms (Fig. 3). The second Rieske histidine ligand (H161ISP)
d the reduced complex with UST bound.
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between oxidised USTand the Rieske cluster can only be formed
if the Rieske cluster is reduced. This observation is consistent
with the experimentally detected preferential binding of
stigmatellin to the reduced Rieske cluster [49,50]. In stigma-
tellin-inhibited cytochrome bc1, only the Glu-FeS conformation
of the Qo-site is populated. It was thus not necessary to consider
conformational variability of the UST-inhibited Qo-site.
3.5. Redox-linked protonation state changes in the Qi-site
In the Qi-site, four titratable groups show noticeably redox-
dependent titration behaviour. H202CYB and D229CYB are the
two primary ligands of CoQ in the Qi-site (Fig. 8). Both show a
lower protonation probability in the oxidised than in the reduced
complex (Fig. 9A and B). K228CYB and K296CYC1 are the other
two Qi-site residues that have redox-dependent protonation
probabilities. Their behaviour is less simple to describe than in
the case of the direct CoQ-ligands: in both redox states of the
complex, the titration curves of K228CYB (Fig. 9C) and
K296CYB (Fig. 9D) display irregular features.Fig. 8. The Qi-site of cytochrome bc1. The relevant portions of the cytochrome b subu
shown in turquoise. Residues that undergo redox-linked protonation state changes
cardiolipin molecule, and the lysine cluster around K296CYC1. K296CYC1 is exposed t
between the two bundles of transmembrane helices of the dimeric complex. All ot
prepared from the HDBT-inhibited crystal structure of cytochrome bc1 from S. cereThe non-standard titration curve of K228CYB in oxidised
cytochrome bc1 (Fig. 9C, solid line) is due to its interaction with
D229CYB and K296CYC1. In Fig. 10A, the protonation
probabilities of K228CYB (dashed line) and D229CYB (dotted
line) in the oxidised complex are shown together with their
correlation (solid line). K228CYB and D229CYB display strong
negative correlation between pH 6 and pH 12: as D229CYB
becomes deprotonated in this pH-range, the probability to find a
proton on K228CYB increases, even though the proton
concentration in the medium decreases. The carboxy carbon
atom of D229CYB is located at a distance of 9 Å from the
sidechain nitrogen atom of K228CYB (Fig. 8). The correlation
between K228CYB and K296CYC1 in oxidised cytochrome bc1
(Fig. 9B, solid line) is weaker than the correlation between
K228CYB and D229CYB (Fig. 9A, solid line), but similar in
shape, and K296CYC1 shows a titration behaviour very similar to
that of D229CYB (Fig. 9A and B, dotted lines). The distance
between the sidechain nitrogen atoms of K228CYB and
K296CYC1 is 7 Å (Fig. 8). The interactions of K228CYB with
D229CYB and K296CYC1 thus act synergistically, rendering the
titration curve of K228CYB highly irregular.nit are shown in green, the transmembrane helix of the cytochrome c1 subunit is
are highlighted, together with haem bH, the substrate CoQ, a tightly bound
o the aqueous phase of the mitochondrial matrix, H202CYB has access to the cleft
her highlighted protein residues are buried within the protein. The figure was
visiae [30].
Fig. 9. Residues in the Qi-site changing their titration behaviour between the completely reduced and completely oxidised state of cytochrome bc1.
Fig. 10. Correlation of the protonation probabilities of K228CYB, D229CYB, K289CYC1 and K296CYC1 can explain the irregular titration curves of K228CYB and
K296CYC1 in completely reduced and completely oxidised cytochrome bc1. Each panel shows the protonation probability of two residues (dashed and dotted lines) and
their correlation ci,j (solid lines). If ci,j takes values close to −0.25 (see Eq. (2)) deprotonation of group i favours protonation of group j, and vice versa.
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(pH) of K228CYB (Figs. 9C, 10C and D, dashed lines) has
irregular features that can be explained from its correlation with
the protonation probabilities of D229CYB and K296CYC1. The
unusual increase in protonation probability of K228CYB between
pH 5 and pH 7 (Fig. 10C, dashed line) is due to its fairly negative
correlation (Fig. 10C, solid line) with the decreasing protonation
probability of K296CYC1 (Fig. 10C, dotted line). Above pH 11,
the protonation probabilities of D229CYB and K228CYB have a
negative correlation (Fig. 10D, solid line): deprotonation of
D229CYB above pH 11 (Fig. 10D, dotted line) leads to an
increased protonation probability of K228CYB (Fig. 10D, dashed
line).
The non-sigmoidal titration curve of K296CYC1 in the
oxidised system (Fig. 9D, solid line) can be explained from its
interaction with K289CYC1. The protonation probabilities of
these two lysine residues have a negative correlation between pH
7 and pH 10 (Fig. 10E, solid line). As K289CYC1 starts to
deprotonate in this pH-range (Fig. 10E, dashed line), the
protonation probability of K296CYC1 (Fig. 10E, dotted line)
remains higher than it would be expected for a standard
sigmoidal titration curve, introducing a kink in the titration curve
of K296CYC1 at pH 8. The sidechain nitrogen atoms of
K289CYC1 and K296CYC1 are separated by 7 Å (Fig. 8).
The titration curve of K296CYC1 in reduced cytochrome bc1
(Fig. 9D, dashed line) shows two flat, non-sigmoidal segments.
Below pH 4, a relatively weak negative correlation between
K296CYC1 and K228CYB (Fig. 10C, solid line) renders the
protonation probability of both residues virtually independent of
pH (Fig. 9C, dashed and dotted lines). Between pH 8 and pH 12,
the observed increase in protonation probability of K296CYC1
compared to the standard sigmoidal shape is due to interaction
with K289CYC1. Similar to the situation in the oxidised system
(Fig. 10E), deprotonation of K289CYC1 in this pH-range (Fig.
10F, dashed line) shifts deprotonation of K296CYC1 (Fig. 10F,
dotted line) to higher pH values (strong negative correlation,
solid line in Fig. 10F).
3.6. Effect of the membrane model on the titration behaviour of
cytochrome bc1
Since the CoQ-binding sites are known to lie at the interface
of the hydrophobic membrane core and the hydrophilic lipid
head group region, it is essential to consider the dielectric effect
of the membrane in any attempt to calculate mechanistically
relevant protonation probabilities. The positioning of the model
membrane around the protein complex can be derived from the
crystal structures: the dimer symmetry axis of cytochrome bc1
corresponds to its membrane normal, and the position of the
membrane along the membrane normal can be derived from the
coordinates of native lipids from both monolayers of the inner
mitochondrial membrane that were retained during the crystal-
lisation procedure [29,30].
In order to characterise the effect of the model membrane on
the titration behaviour of cytochrome bc1, we have performed
separate PB/MC titration calculations on the complex with and
without model membrane. In both calculations cytochrome bc1was assumed to be fully reduced. All residues that are found to
be influenced by the addition of the model membrane are located
at the boundary of the membrane or in the transmembrane region
of the complex. Their titration behaviour with and without
model membrane is discussed in the following.
As obvious from Fig. 11, the hydrophobic membrane
environment favours the neutral protonation form over the
charged protonation form of all affected residues. In the
hydrophobic, that means only weakly polarisable environment
of the membrane, charges are destabilised in comparison to a
highly polarisable aqueous solution. For example, the protona-
tion probabilities of Y55ISP (Fig. 11A) and Y68SU9 (Fig. 11B),
which are equivalent to the probabilities to find them in their
neutral protonation form, are increased upon addition of the
membrane. Fig. 11C demonstrates that the unusually high
protonation probability of D229CYB (also shown in Fig. 9B) is
not an artefact caused by the model membrane, since this residue
has a high protonation probability also in absence of the
membrane (Fig. 11C, solid line).
K228CYB displays a highly unusual titration behaviour both
with and without membrane model (Fig. 11D). The shape of the
curve calculated for the complex without membrane is due to
interaction with the neighbouring residues D229CYB, K296CYC1
and the propionate A moiety of haem bH (Fig. 12). The unusual
rise in protonation probability of K228CYB between pH 0 and pH
2 (Fig. 12A, dashed line) can be rationalised from its negative
correlation (Fig. 12A, solid line) with the decreasing protonation
probability of propionate A of haem bH (Fig. 12A, dotted line):
their negative correlation means that deprotonation of the
propionate favours protonation of K228CYB. The distance
between the carboxy carbon atom of the haem propionate and
the sidechain nitrogen atom of K228CYB is 11 Å (Fig. 8). The
second and even more pronounced rise in protonation
probability of K228CYB between pH 6 and 13 (Fig. 12B and
C, dashed line) can be explained from negative correlation (Fig.
12B and C, solid lines) with the titration curves of K296CYC1
(Fig. 12B, dotted line) and D229CYB (Fig. 12C, dotted line),
respectively, in the pH-range from 6 to 9 and 9 to 13. K296CYC1
starts to deprotonate at pH 6, D229CYB at pH 9. Correlation data
rationalising the shape of the titration curve of K228CYB in the
complex with model membrane has been discussed above and is
presented in Fig. 10A to D.
K72ISP and E76ISP lie in the transmembrane region of the
complex. As has been discussed in the context of the structure of
cytochrome bc1 from chicken [51], the transmembrane helix of
the ISP subunit has conserved amphipathic features. In crystal
structures of chicken and bovine cytochrome bc1 [52–57], the
hydrophilic patches of the ISP transmembrane helix interact with
subunit 10, a small and loosely bound subunit that is not
contained in the crystal structures of cytochrome bc1 from S.
cerevisiae. In our calculations, which are based on the crystal
structures from S. cerevisiae, K72ISP and E76ISP are thus not
involved in interaction with subunit 10, but are exposed to the
hydrophobic membrane environment. The effect of the mem-
brane model on their titration behaviour in the reduced system is
shown in Fig. 11E and F (solid and dashed lines). In presence of
the membrane model we observe redox-linked changes in the
Fig. 11. Residues changing their titration behaviour upon addition of the model membrane. K72ISP and E76ISP lie in the transmembrane region of the complex, all other
residues at the boundary of the model membrane. The titration behaviour of Y55ISP and Y68SU9 is independent of the redox state of the system, data shown has been
obtained for the fully reduced state. Redox-dependent changes in the titration behaviour of the Qi-site residues D229
CYB and K228CYB are included in Fig. 9.
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and E76ISP (Fig. 11F, dashed and dotted lines) that can be
interpreted as a shared proton of a hydrogen bond between
K72ISP and E76ISP moving slightly from E76ISP towards K72ISP
upon reduction of the complex. The Nζ atom of K72ISP is
located at a distance of 3 Å from the Oε1 atom of E76ISP. The
protonation probabilities of K72ISP and E76ISP show a strong
negative correlation when the membrane model is added. This
effect is however not considered to have functional relevance in
the cytochrome bc1 complex containing subunit 10, and has
therefore not been included into Fig. 5 or 9.
3.7. Proton uptake upon reduction of cytochrome bc1
From the sum of the protonation probabilities of all titratable
residues in oxidised and reduced cytochrome bc1, the overall
difference in the number of protons bound to the oxidised and
reduced complex can be calculated for every pH-value. The
number of protons in the reduced complex minus the number of
protons in the oxidised complex is equivalent to the number of
protons taken up by cytochrome bc1 upon conversion from the
oxidised to the reduced state.Upon complete reduction of the complex, approximately
three protons are taken up by each half of the dimeric complex
(Fig. 13A, solid line). The uptake shows a non-linear
dependence on pH. Only the protons taken up by protein
residues are considered for this figure, protons of the Q/QH2
couple are not counted. Upon conversion from the completely
oxidised to the completely reduced state of the system, one
electron is bound by each of the four redox cofactors (the Rieske
cluster, haem bL, haem bH, and haem c1). The increase in
negative charge of the complex is thus compensated to about
75% by the uptake of about three protons.
4. Discussion
4.1. The conformational variability of E272CYB may play a role
in gating of CoQ oxidation
Dutton and coworkers [19,58] have recently elaborated on an
aspect of Qo-site catalysis that has previously not attracted much
attention. Since the electron transfer reactions in cytochrome
bc1 are largely reversible at least under certain experimental
conditions, a control mechanism must exist that prevents
Fig. 12. Strong correlation with the protonation probabilities of D229CYB,
K296CYC1, and the propionate A moiety of haem bH explain the irregular
titration behaviour of K228CYB in the fully reduced complex without model
membrane. Each panel shows the pairwise correlation ci,j (see Eq. (2)) between
K228CYB and one of these residues (solid lines), and the corresponding
protonation probabilities (dashed and dotted lines).
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emphasised the need for a gating mechanism that allows CoQ
oxidation only if the two electrons can be transferred to the two
distinct electron acceptor groups. A simple scenario has been
proposed [20,30] that would in fact represent such a gating
mechanism: redox-dependent changes in the hydrogen-bond
interactions between CoQ and the Qo-site should allow binding
of reduced CoQ only if both the Rieske cluster and haem bL are
oxidised. Mulkidjanian [6] introduced a similar idea where CoQ
oxidation is additionally controlled by conformational changes
of E272CYB.
In our calculations, E272CYB occupies its Glu-b position in
both completely reduced and completely oxidised cytochrome
bc1 with reduced and oxidised CoQ in the Qo-site, respectively
(Fig. 4). In the Glu-b conformation, the carboxy group of
E272CYB is located at a distance of 8 Å from the closest CoQ
oxygen atom and is thus unlikely to strongly interact with an
uncharged CoQ (Fig. 3). The sidechain of E272CYB does thus
not contribute to the binding of CoQ if CoQ and the redoxcofactors of the complex are in the same redox state. In the UST-
inhibited complex, where E272CYB is in its Glu-FeS position,
both E272CYB and H181ISP show redox-dependent changes in
titration behaviour that are in agreement with their proposed
role as primary proton acceptors (Fig. 7). When E272CYB is in
its Glu-b conformation, neither E272CYB (Fig. 5A) nor H181ISP
display considerable redox-linked protonation state changes
(H181ISP remains protonated over the considered pH-range in
both the completely oxidised and the completely reduced state).
These results are consistent with the mechanism proposed by
Mulkidjanian (see below and Ref. [6]).
Since the relative population of the two different conforma-
tions of the Qo-site depends on pH and on the redox state of the
complex (Fig. 4), it is tempting to assume that E272CYB may
occupy its Glu-FeS position in other combinations of the redox
states of CoQ and the protein cofactors. In the Glu-FeS position,
the sidechain of E272CYB is most likely a primary ligand to CoQ,
since it directly interacts with the inhibitor stigmatellin in the
respective crystal structures [4,28,29,56,57,59,60]. Our results
for the completely reduced and completely oxidised complex
still allow for the conformational variability of E272CYB being a
mechanistic basis for the gating of CoQ oxidation in the Qo-site.
The following scenario for the gating of CoQ oxidation in the
Qo-site by means of a change of its conformation and
protonation is thus consistent with our data (compare Ref. [6]):
if reduced and protonated CoQ enters into the Qo-site of reduced
cytochrome bc1 it cannot bind strongly because the sidechain of
E272CYB is in its Glu-b position and pointing away from the
binding site. Also the Rieske ligand H181ISP is protonated and
cannot serve as a hydrogen bond acceptor. In contrast, if reduced
and protonated CoQ binds to oxidised cytochrome bc1 (that is
not the oxidised and deprotonated form present in our
calculations on the oxidised complex), E272CYB may occupy
its Glu-FeS position. H181ISP and E272CYB would then be
deprotonated and ready to bind the quinol by each accepting a
hydrogen bond. Both H181ISP and E272CYB would in this
situation show redox-linked changes in their protonation
probabilities, which makes them likely candidates for the uptake
of one proton each upon electron transfer from CoQ to the
Rieske cluster and haem bL.
4.2. Coupling between reduction and protonation of haem bL
and the Rieske cluster
The redox-linked change in the protonation probability of the
propionate A of haem bL (Fig. 5D) points to a coupling between
the reduction and protonation of this cofactor. Such an effect
would support the parallel movement of an electron and a
proton from reduced CoQ towards haem bL [9,28]. The
movement of compensating charges may be energetically
favourable for electron transfer from CoQ to haem bL. Electron
transfer within cytochrome b has in fact been reported to be
electrogenically silent even up to the stage of CoQ reduction in
the Qi-site [6].
As obvious from the data presented in Fig. 5E, the Rieske
histidine ligand H161ISP shows a strong dependence of its
protonation probability on the redox state of the system.
Fig. 13. Proton uptake upon reduction of cytochrome bc1. (A) The total number of protons taken up by one half of the dimeric system is shown as solid line. The
contributions of all titratable residues have been considered to calculate this quantity. The dashed line shows the number of protons taken up by only a subset of the
titratable residues (H141CYB, H253CYB, E272CYB, H161ISP, propionate A of haem bL, H202
CYB, K228CYB, D229CYB, K296CYC1 and propionate D of haem c1). (B)
Contributions of the individual residues that add up to the dashed line in panel A.
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cluster in isolated ISP fragments has been reported
[8,9,15,28,61], and protonation state changes of the Rieske
cluster have also been observed in FTIR experiments in the
context of the cytochrome bc1 complex [27]. The latter results
are largely equivalent to our data, but in the experiments the Qo-
site is most likely empty, and the localisation of the mobile ISP
head domain at the Qo-site interface with cytochrome b is
therefore not assured [4,53,62]. Our calculations now provide
evidence that the coupling between protonation and reduction
of the Rieske cluster plays a role also in the structural context of
the Qo-site.
4.3. Primary proton donor groups and proton uptake towards
the Qi-site
H202CYB and D229CYB are primary ligands of CoQ in the
Qi-site (Fig. 8). Our results for their protonation probabilities are
consistent with the role of these residues as primary proton
donor groups during CoQ reduction in the Qi-site: when haem
bH gets oxidised via electron transfer to CoQ in the Qi-site, the
protonation probabilities of H202CYB and D229CYB are likely
to decrease as observed in our calculations (Fig. 9A and B).
Protons from these two residues could then easily be transferred
to the CoQ molecule in the Qi-site.
The highly irregular titration behaviour of K228CYB and
K296CYC1, together with their correlation with D229CYB and
K289CYC1, respectively, shows that the titratable residues of the
Qi-site form a network of strongly interacting groups. It is
important to quantify the effect of electrostatic interactionbetween these titratable residues to assess their role in proton
uptake to the Qi-site. Non-standard titration curves of individual
titratable groups in proteins are in general due to strong
electrostatic interaction with at least one other titratable group
[48], meaning that the pairwise interaction energy Wi,j (Eq. (1))
takes a large value. However, since the interaction energyWi,j is
a pH-independent quantity, the correlation ci,j (pH) between the
titration curves 〈xi〉(pH) and 〈xj〉(pH) of two interacting groups i
and j is a more significant and intuitive tool to rationalise the
non-standard titration curves of interacting groups: strongly
interacting groups that titrate in the same pH-range are likely to
show correlation of their protonation probabilities, but the
correlation may vary with pH. The correlation ci,j (pH) (Eq. (2))
is a unitless number that takes values between −0.25 and +0.25.
A relatively large and negative value of ci,j (pH) means that
protonation of group i disfavours protonation of group j, and
vice versa.
Because of the strong correlation of the protonation
probabilities of K228CYB, D229CYB and K296CYC1 we propose
that these residues form a concerted device for proton uptake to
the Qi-site. While the putative primary proton donor group
D229CYB is buried within the protein, K296CYC1 is exposed to
the aqueous phase of the mitochondrial matrix. K228CYB is
located between K296CYC1 and D229CYB (Fig. 8). Protons from
the mitochondrial matrix might therefore reach the Qi-site via
K296CYC1 and K228CYB. K228CYB and K296CYC1 are con-
served over a wide range of species. The unusual, non-sigmoidal
titration curves of K228CYB show that the protonation state of
this residue is highly ambivalent, which makes it a likely residue
to be involved in proton transfer. Besides, K228CYB is part of a
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K289CYC1 and K296CYC1; Fig. 8) that also display relatively
strong correlations of their protonation probabilities. This lysine
cluster may act as a proton sink to increase the probability of
protons reaching the Qi-site.
Previous investigations of the structure of the Qi-site of
cytochrome bc1 from S. cerevisiae have proposed different
possibilities of proton uptake towards D229CYB [9,29]. Lange
et al. [29] have discussed the so-called CDL/K-pathway as one
possible route of proton uptake towards D229CYB. They
proposed a role in proton uptake for the tightly bound cardiolipin
molecule (CDL) located close to K228CYB (Fig. 8). Our
calculations indicate that CDL is not directly involved in proton
uptake since both of its phosphate moieties remain deprotonated
between pH 0 and pH 14 in both redox states of the complex.
Instead, K296CYB and the surrounding lysine residues may take
the role of the primary proton uptake group. The cardiolipin
molecule can still have an essential role in stabilising protons in
this lysine cluster: the protonation probabilities of K288CYC1
(Fig. 14A) and K289CYC1 (Fig. 14B) drop dramatically if the
CDL molecule is omitted from the calculations. Other residues
are not affected substantially by the presence or absence of CDL.
4.4. Account of the membrane model
The need to include a membrane model in PB-calculations
on cytochrome bc1 is immediately evident from the location of
the CoQ-binding sites at the interface of the hydrophobic
membrane core and the hydrophilic lipid head group region of
the mitochondrial membrane. We employ a straight-forward
model of the membrane that assumes a low dielectric constantFig. 14. Effect of cardiolipin (CDL) on the titration behaviour of residues located
close to the Qi-site of cytochrome bc1. Results shown were obtained for
completely reduced cytochrome bc1, neither of the two residues shows redox-
dependent titration behaviour.for the membrane core (the same as for the protein) and a high
dielectric constant for the lipid head group region (the same as
for the aqueous phase). Our model has the advantage to be
applicable to all three-dimensional arrangements of protein/
membrane and protein/water interfaces. Future approaches to
PB-calculations on membrane proteins will ideally combine this
feature with a more accurate treatment of the headgroup region.
The thorough test calculations on the effect of the model
membrane show that it yields reasonable results since the
titration behaviour of all affected residues is changed towards a
stabilisation of the uncharged forms. At the same time, the
dominant features in the titration curves of the relevant Qi-site
residues D229CYB (high protonation probability even at high
pH) and K228CYB (intermediate protonation probability that is
only weakly pH-dependent) are evident also in absence of the
membrane model. We therefore conclude that the unusual
titration behaviour of these residues is not an artefact of the
calculation setup but is relevant to the understanding of the
catalytic mechanism of cytochrome bc1.
4.5. Comparison of calculated protonation probabilities and
FTIR data
Several FTIR experiments have been performed in recent
years to identify redox-dependent protonation state changes in
cytochrome bc1 [22–27]. In these studies, the completely
reduced system is converted into the completely oxidised
system, and redox-dependent FTIR difference spectra are
recorded during this transition.
For the Qo-site, direct comparison of FTIR data and
calculated protonation probabilities is possible for the results
obtained with an UST-inhibited Qo-site, since in this case the
conditions of experiment and calculations are largely equiva-
lent. Upon reduction of haem bL, Ritter et al. [25] observe a
change in a signal assigned to a propionate group. In our
calculations with UST none of the propionate groups of
cytochrome bc1 displays noticeable redox-linked changes in
its protonation probability. Since the discrimination of FTIR
signals from propionate and sidechain carboxy groups is often
not trivial, we propose that the observed signal may originate
from the marked redox-dependence of the protonation prob-
ability of E272CYB (Fig. 7). In the UST-inhibited complex the
sidechain of E272CYB is located at a distance of only 7.7 Å from
the haem porphyrin ring system which makes it a likely
candidate for coupling to the reduction of haem bL.
Apart from the work on UST-inhibited cytochrome bc1, most
of the available FTIR data has been obtained with an empty Qo-
site. If the Qo-site is empty, the ISP head domain will occupy
many different positions, as indicated by an early crystal-
lographic study of uninhibited cytochrome bc1 that could not
resolve the ISP head domain [52]. It can be assumed that the
mobile and consequently well solvated ISP head domain will in
this situation have little effect on the electrostatics of the rest of
the complex. To mimic the experimental conditions of the FTIR
studies of uninhibited cytochrome bc1 we have therefore
characterised the titration behaviour of reduced cytochrome
bc1 with an empty Qo-site in the Glu-b conformation and
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virtually identical to the results for the complete system with
CoQ in the Qo-site. The results presented above can therefore
reasonably be compared to the available FTIR data also without
UST in the Qo-site, keeping in mind that we can however not
easily decide on the conformation of the cytochrome b part of
the empty Qo-site. More detailed structural information is
required to asses this question in PB/MC titration calculations.
Baymann et al. [22] observe the protonation of a carboxylic
group to be coupled to the reduction of haem bL, and propose
E272CYB as a likely candidate responsible for this effect. From
our calculations with CoQ in the Qo-site, E272
CYB shows only a
slightly higher protonation probability in the completely
reduced compared to the completely oxidised complex. Since
the Qo-site is however empty in the experiments, E272
CYB may
occupy its Glu-FeS position. For this scenario, we expect from
our data a marked increase in the protonation probability of
E272CYB upon reduction of the protein complex, which is in
agreement with the experimental data. Ritter et al. [23] observe
changes in a signal from a propionate group upon reduction of
haem c1, which fits with the redox-linked changes in titration
behaviour of the propionate D moiety of haem c1 in our
calculations. Iwaki et al. [27] report redox-linked changes in the
protonation state of the Rieske ligand histidines that are in
agreement with our results. Ritter et al. [23,25] report an
unexpected protonation of a carboxylic residue upon oxidation
of the complex. In our calculation, we cannot identify a residue
undergoing an equivalent redox-linked change in protonation
state. However, Baymann et al. [22] observe the protonation of
a carboxylic group upon reduction of haem bH. Our results fit
well with these latter data: we observe the protonation of
D229CYB to be coupled to reduction of cytochrome bc1 (Fig.
9B). The specific coupling between haem bH and D229
CYB can
be concluded from their close spatial proximity (Fig. 8).
4.6. Proton uptake upon reduction of cytochrome bc1
The shape of the proton uptake curve vs. pH (relatively high
values at pH 3 and pH>10, Fig. 13A, solid line) can be
rationalised by a simple statistical consideration. In a system
with multiple titratable groups, the titration behaviour of the
individual groups can differ considerably from their behaviour
as isolated group in aqueous solution. However, the majority of
all titratable groups will be solvent exposed and still titrate in a
pH-range around their solution pK-values. Thus, at pH-values
around 4, the majority of the carboxylic residues will titrate. At
pH-values above 10, the majority of the arginine and lysine
residues will titrate. In the intermediate pH-region, only the
histidine residues are likely to titrate, and their number is much
lower than the number of carboxylic, arginine and lysine
residues (43 histidines vs. 192 carboxylic residues and 203
arginine and lysine residues in each half of the dimeric
complex). If many residues are likely to titrate at a certain
pH-value, small redox-linked changes in the protonation
probabilities of some of these residues will add up to a
considerable value. Such relatively high values of the sum of
redox-linked changes in protonation probabilities correspond tothe high values for proton uptake upon reduction at pH 4
(carboxylic residues) and above pH 10 (arginine and lysine
residues). The relative frequency of the different types of
titratable residues can thus roughly rationalise the shape of the
proton uptake curve.
In our analysis of the redox-linked changes in titration
behaviour of cytochrome bc1 we focus on those residues that
have an rmsd between their titration curves in the oxidised and
reduced state (over the pH-range from 0 to 14) that exceeds a
threshold value of 0.2. Based on this selection criterion, we
discuss the titration behaviour of the following residues:
propionate D of haem c1, the Qo-site residues H141
CYB,
H253CYB, E272CYB, H161ISP and propionate A of haem bL,
and the Qi-site residues H202
CYB, K228CYB, D229CYB and
K296CYC1. The proton uptake that can be attributed to this set of
ten groups is shown in Fig. 13A (dashed line), and the
contribution of the individual residues is shown in Fig. 13B.
The total proton uptake of the altogether 554 titratable residues
in each half of the dimeric complex has a slightly different pH-
dependence than the uptake by the set of selected residues,
especially in the pH range from 7 to 12. Therefore, also residues
that undergo only subtle redox-linked changes in their titration
behaviour and are thus not discussed explicitly, make a
contribution to the total uptake of protons upon reduction of
cytochrome bc1. If one considers however that the set of
selected residues comprises less than 2% of the total number of
titratable residues in the system, the difference between the two
proton uptake curves is small. The residues that are most
important for redox-linked protonation state changes in
cytochrome bc1 have thus been discussed above.
5. Conclusions
By performing Poisson–Boltzmann/Monte Carlo titration
calculations, we have obtained protonation probabilities for
completely oxidised cytochrome bc1 with oxidised and
deprotonated CoQ or undecylstigmatellin in the Qo-site, and
completely reduced cytochrome bc1 with reduced and proto-
nated CoQ or UST bound. We could identify a small number of
residues in the protein complex which show different titration
behaviour in the completely reduced and the completely
oxidised state of cytochrome bc1. The obtained results are
largely consistent with the available FTIR data [22–27]. In
addition to the protonation probabilities, we have calculated the
population of two different conformations of the Qo-site as a
function of ambient pH and of the redox state of the complex.
E272CYB has been shown to occupy different positions in the
Qo-site: in stigmatellin-inhibited cytochrome bc1 the sidechain
of E272CYB binds stigmatellin together with the Rieske cluster
(conformation Glu-FeS), while in the HDBT-inhibited complex
it points away from the inhibitor and towards haem bL
(conformation Glu-b). Our calculations indicate that in presence
of CoQ modelled into the Qo-site both the completely reduced
and the completely oxidised complex populate primarily the
Glu-b conformation. However, the relative population of the
two conformations depends on pH as well as on the redox state
of the complex. In the completely reduced state of cytochrome
219A.R. Klingen et al. / Biochimica et Biophysica Acta 1767 (2007) 204–221bc1 also the Glu-FeS conformation of the Qo-site is considerably
populated in the physiological pH range. Our data thus indicate
that the two crystallographically observed conformations of the
Qo-site can be populated in the uninhibited complex, and that
the corresponding conformational change may well play a role
during turnover of the Qo-site.
The calculated protonation probabilities and populations of
the different Qo-site conformations have mechanistic implica-
tions for Qo-site catalysis. We have shown that coupling
between the reduction and protonation of the Rieske cluster
plays a role also in the context of the Qo-site with bound CoQ.
The redox-linked change in the protonation probability of
propionate A of haem bL supports a proposed parallel
movement of an electron and a proton from CoQ to haem bL.
The observed redox-dependence of the population of the
different Qo-site conformations and of the protonation prob-
ability of E272CYB imply, that a change of the conformation and
protonation of E272CYB will most likely be involved in the CoQ
oxidation reaction. The conformational transition of E272CYB
and resulting changes in the protonation pattern of the Qo-site
may be the basis of a redox-dependent gating of CoQ binding to
the protein complex: if CoQ and the redox cofactors of
cytochrome bc1 are in the same redox state, CoQ cannot bind
strongly since E272CYB is in its Glu-b position and points away
from the binding site. In this situation, neither of the two
postulated primary proton acceptor groups of the CoQ oxidation
reaction (E272CYB and the Rieske ligand H181ISP) display
redox-dependent protonation probabilities that would fit with
the proposed catalytic function.
If H161ISP undergoes protonation upon reduction, if
E272CYB is in its Glu-b conformation, only the second Rieske
histidine ligand, H161ISP undergoes protonation upon reduc-
tion. However, E272CYB may occupy its Glu-FeS conformation
when reduced and protonated CoQ binds to oxidised cyto-
chrome bc1. The conformational change of E272
CYB induces
changes in the protonation pattern of the Rieske cluster and the
E272CYB sidechain, so that both E272CYB and H181ISP are then
likely proton acceptor groups. In the future, we will test the
implications of our present work by calculating protonation
probabilities for combinations of redox states of CoQ and the
protein complex that are possible intermediates of cytochrome
bc1 turnover.
Concerning the Qi-site, our results are in agreement with the
role of H202CYB and D229CYB as primary proton donor groups
during the reduction of quinone. Based on calculated redox-
linked changes in protonation probabilities, strong correlation
of protonation probabilities, and an analysis of the solvent-
exposure of contributing residues, we propose that residues
K296CYC1, K288CYB and D229CYB form a concerted device for
proton uptake towards the Qi-site. The negatively charged
headgroup of the cardiolipin molecule located close to the Qi-
site stabilises protons in a cluster of lysine residues around
K296CYC1.
To the best of our knowledge, the present paper is the first
report of a quantitative theoretical investigation of the titration
behaviour of a system as large as cytochrome bc1, based on
physical principles and structural data at atomic detail. Wepresent here calculations of protonation probabilities that have
been performed in order to mimic the experimental setup of
recently published FTIR experiments. Our results are in
agreement with experimental data and aid in the understanding
of the molecular mechanism of cytochrome bc1.
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